March 31, 2025 10:48 AM EDT
People
Startups

In­spir­na, which was prepar­ing for a Phase 3 can­cer tri­al, has fold­ed

Kyle LaHucik

Senior Reporter

A New York City drug de­vel­op­er led by well-known ex­ec­u­tives and backed by some of the top names in biotech in­vest­ing is shut­ting down, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

RFK Jr. has long crit­i­cized drug ads. He just slashed the FDA of­fice that reg­u­lates them

Fir­ings sweep across FDA as for­mer lead­ers lament the gut­ting of drug agency

‘It’ll be a chal­lenge’: BIO chief Crow­ley ad­dress­es seis­mic FDA over­haul

Sanofi con­tin­ues its bet on R&D by poach­ing GSK’s head of de­vel­op­ment

Big am­bi­tions at Mer­ck and As­traZeneca — along with a few gi­ant pit­falls — re­shape top ranks of the R&D 15

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times